Articles tagged with Hemodialysis
UF researchers found that patients who wait longer for a kidney transplant are more likely to experience poorer outcomes. The study showed that even those who receive kidneys from living donors may not reap the full benefits if they have been on dialysis for too long.
Researchers found that high levels of C-reactive protein and low albumin are associated with a higher risk of cardiovascular disease in dialysis patients. The study, which followed over 1,000 patients for four months, found that these proteins can identify patients at high risk before heart events occur.
A new non-calcium phosphate binder, lanthanum carbonate (Fosrenol), has shown a reduction in mortality and cardiac death among kidney patients on hemodialysis compared to conventional phosphate binders. The study involved 647 patients who received Fosrenol therapy for two years.
A Johns Hopkins-led study found that delayed evaluation by a nephrologist increases mortality risk among chronic kidney disease patients. Early evaluation was associated with lower death rates, highlighting the importance of timely specialist care.
The USPSTF recommends that physicians routinely screen women over 65 for osteoporosis, a thinning of the bones that can lead to bone fracture. Women at higher than average risk should begin screening at age 60. Early nephrologist care is associated with better outcomes for kidney disease patients, particularly those with African-Americ...
Researchers have made significant strides in artificial liver technology, with 20 patients using the albumin dialysis approach in a phase I trial. The system has shown promise in reducing blood toxins and reversing coma and shock, offering hope to those waiting for liver transplants.
A landmark study suggests that at-home dialysis therapy can be more flexible and manageable than previously thought. The ADEMEX study found that increasing small solute clearances did not impact patient survival rates, and body size, transport status, and other factors had no measurable effect on outcomes.
Researchers identified three barriers to adequate dialysis: inadequate prescriptions, catheter use, and shortened treatment time. Interventions addressed these barriers, resulting in higher quality treatment and improved patient outcomes. The study aims to re-examine the federal reimbursement system to encourage high-quality care.
Biocompatible thin films have been successfully fabricated on various biomedical substrates using electrostatic self-assembly techniques. These films can inhibit restenosis, a tissue buildup that occurs in blood vessels after trauma, and have potential applications in stents and dialysis tubing.
A study of dialysis patients found that high pulse pressure is associated with a greater risk of death, contradicting the idea that lower blood pressure is better. Researchers analyzed over 37,000 patients and discovered that the difference between systolic and diastolic blood pressures can indicate mortality risk.
The HomeChoice Pediatric dialysis system is designed to meet the special needs of young patients with ESRD, offering a safe and flexible option for administering dialysis at home. The system integrates Baxter's PD Link software, enabling remote monitoring and data analysis.
The ADEMEX study found that increasing small solute clearances through modified dosing doesn't impact patient survival, contrary to current practice. This enables tailored prescriptions for individual patients without sacrificing survival benefits.
A new operations research model has the potential to reduce America's high mortality rate for those with End Stage Renal Disease (ESRD) by as much as 20%, while also containing budget costs. The model helps dialysis centers optimize treatment and reduce financial burden.
Dialysis patients who took amino acid supplements experienced a significant increase in albumin levels, with an average rise of 0.22 g/dL for hemodialysis patients and 0.01 g/dL for peritoneal dialysis patients. This study suggests that simple nutritional interventions can have a positive impact on the health of dialysis patients.
A study of over 50,000 transplant recipients found that kidney transplants from living donors are more cost-effective than dialysis treatments. The total cost of care within five years is roughly $47,000 less for living donor transplants compared to dialysis.
A new study found that anabolic steroids can increase lean body mass and reduce fatigue in kidney disease patients receiving dialysis. Patients who received the steroid gained an average of 5.7 pounds more lean body mass than those on placebo, scoring better on physical performance tests.
A Wake Forest University study found that US dialysis patients are more likely to miss treatment sessions compared to their European and Asian counterparts. Factors contributing to this discrepancy include differences in dialysis prescription, patient health, medical system eligibility, and patient independence.
A low-protein diet can safely delay dialysis treatment for up to a year in patients with severe chronic renal failure. The diet, rich in fruits and vegetables, provides essential nutrients without side effects.
In a groundbreaking case, doctors at the University of Maryland Medical Center reversed kidney failure in an HIV-infected patient by putting them on high-intensity antiretroviral therapy. The patient's kidneys regained normal function, and their viral load decreased significantly.
Researchers found that black children are nearly 2.5 times more likely than white children to receive hemodialysis versus peritoneal dialysis. The disparity was observed across different age groups, with younger black children being most likely to opt for hemodialysis.